OBJECTIVE To investigate the allocation of antipsycho tics in regions with different economic levels in Shandong province，and to provide reference for strengthening the management of antipsychotics allocation and promoting the balance of regional allocation. METHODS The procurement information of the secondary and tertiary public medical institutions in Shandong province from 2016 to 2019 was collected from the Drug Centralized Bidding and Procurement Information Platform of Shandong Provincial Medical Institutions. The procurement varieties of antipsychotics ，allocation proportion and procurement cost per 10 000 people were analyzed in area with different economic levels in Shandong province. RESULTS From 2016 to 2019，there were 18 kinds of antipsychotics purchased by secondary and tertiary public medical institutions in Shandong province （9 kinds of first- and second-generation antipsychotics respectively ），and the average number of purchased varieties were 3.50-4.42. The average number of purchased varieties in undeveloped areas （3.59-4.48 kinds）were slightly higher than that in developed areas （3.41-4.36 kinds）. In these four years ，average allocation proportion of antipsychotics was 17.19％，and most of them showed a fluctuating increase （the average annual increase ranged 4.64％-38.34％）. The allocation proportion of second-generation antipsychotics was higher in developed areas than that in undeveloped areas. The purchasing cost per 10 000 people showed an upward trend of fluctuation ， ranging from 2.45 to 7 440.20 yuan. Among the 18 antipsychotics procured from 2016 to 2019，61.11％，61.11％，83.33％ and 72.22％ of them were procured by developed areas with higher procurement costs per 10 000 people than by undeveloped areas. The total procurement cost of essential medicine per 10，000 people in developed areas （11 382.99-39 650.90 yuan）was also higher than that in undeveloped areas （8 353.15-30 561.77 yuan）. CONCLUSIONS The allocation proportion of antipsychotics is low in Shandong province ，and the allocation proportion of second-generation antipsychotics in developed areas are higher than that in undeveloped areas.